The aim of this study was to assess the epidemiology and molecular basis of the infection and dissemination of multidrug-resistant Acinetobacter baumannii (MDRAB) in three sequential outbreaks at the intensive care units (ICUs) of a tertiary university hospital in Granada, Spain, between 2009 and 2011. Strains from all patients infected and/or colonized by MDRAB during outbreak periods were characterized using PFGE and multilocus sequence typing (MLST). The first outbreak appeared in the summer of 2009 involving 38 ICU patients: 25 from a Traumatology-Rehabilitation hospital (TRH) and 13 from a Medical-Surgery hospital (MSH). Between 2010 and 2011, outbreaks were limited to the MSH-ICU, affecting 9 and 11 patients, respectively. Two PFGE types were detected. In the 2009 outbreak, two clones were identified: profile 1 strains were isolated at the TRH, whilst profile 2 was isolated at the MSH. Only one clone was identified in the 2010 and 2011 outbreaks: the profile 2 clone detected at the MSH in 2009. After MLST analysis, a single sequence type (ST92) was identified. This suggested that an endemic strain could evolve and cause localized outbreaks in vulnerable patients. Multiplex PCR for OXA group enzymes yielded a positive result for bla OXA-58-like and bla OXA-51-like genes, and gene sequencing showed the presence of bla OXA-58 . However, the absence of ISAba1 upstream of the bla OXA-51-like gene suggested the absence of OXA-51 expression. The susceptibility pattern was not an appropriate method for MDRAB surveillance, as several susceptibility patterns were identified in a single clone. Consequently, molecular methods of characterization are recommended for epidemiological surveillance of MDRAB.
INTRODUCTION
Acinetobacter baumannii is an opportunist pathogen that in recent decades has emerged as one of the main causes of nosocomial infection, mainly affecting patients admitted to intensive care units (ICUs). Multidrug resistance (Magiorakos et al. 2012) , including carbapenem resistance, is a common problem in many hospitals. Epidemic outbreaks of multidrugresistant A. baumannii (MDRAB) may become endemic if adequate control measures are not implemented. In a particular hospital, MDRAB strains generally belong to a limited number of clones (Fernádez-Cuenca et al., 2004 ) against which few therapeutic options exist. Resistance to carbapenems in A. baumannii has been mainly associated with the production of class D carbapenemases, such as OXA-23, OXA-24/40, OXA-58 and OXA-51. Whilst OXA-23, OXA-24/ 40 and OXA-58 carbapenemases are mediated by plasmids, the expression of the chromosomic bla OXA-51 gene in A. baumannii has been associated with an upstream ISAba1 insertion (Turton et al., 2006) . This study describes three sequential MDRAB clinical outbreaks that occurred between 2009 and 2011 at the Virgen de Las Nieves University Hospital (VNUH), Granada, Spain. The aim of this study was to assess the epidemiology and molecular basis of the infection and dissemination process of OXA-58-producing A. baumannii in a hospital setting.
METHODS
Study design and bacterial isolates. The VNUH is a third-level hospital complex with 1207 beds, including the following hospitals: the Medical-Surgery hospital (MSH), the Maternity-Children's hospital and the Traumatology-Rehabilitation hospital (TRH), this last one located at some distance from the others. The complex includes two adult ICUs -one in the MSH and another in the TRH.
Between 2009 and 2011, three sequential increases in the isolation of MDRAB were noted in patients admitted to the ICUs of the VNUH, which led our research group to conduct the present study.
For the purposes of this study, we sampled strains from all patients infected and/or colonized by MDRAB during outbreak periods (one isolate per patient, except in 2011, when several isolates per patient were studied). MDRAB infection cases were determined according to the Centers for Disease Control criteria (Garner et al., 1988) . A patient was considered to be colonized when they were found to be a MDRAB carrier without showing any clinical evidence of infection. In 2009, we also examined environmental samples from affected wards.
In all cases, when a potential MDRAB outbreak (three cases coinciding both in space and time) was detected as a result of routine surveillance for MDRAB infection, a multidisciplinary improvement group was created for the control of healthcare-associated infections. This group included hospital managers, medical and nursing staff from the Departments of Disease Prevention and Microbiology, and personnel from the affected ICU. Appropriate infection control measures were immediately adopted. These measures included a weekly culture for detection of MDRAB carriers among ICU patients, restrictions on physical contact and mobility, vigilant hand hygiene, disinfection with alcoholic solutions, and careful cleaning of rooms. Although a variety of culture media have been reported previously for isolation of Acinetobacter spp., we used MacConkey agar and Leeds Acinetobacter Medium (Jawad et al., 1994) .
Species-level identification and antimicrobial susceptibility testing. Species were identified and antibiotic susceptibility was determined using the WIDER system (Francisco Soria Melguizo) and the MIC/ID Gram-negative panels. Carbapenems, colistin and ampicillin/sulbactam susceptibility were determined by E-tests. Results were interpreted according to the CLSI (2011) criteria.
PFGE analysis. The strains were characterized epidemiologically at the National Center of Microbiology by using PFGE and multilocus sequence typing (MLST).
Plug preparation, lysis, cell washing, restriction digestion and electrophoresis were performed as described previously (Seifert et al., 2005) , with slight modifications. The entire chromosomal DNA of the strains was digested with 60 U ApaI. PFGE was performed by using a clamped homogeneous electric field electrophoresis DRIII apparatus (Bio-Rad). These actions were performed at a temperature of 14 uC, a voltage of 6 V cm 21 , a run time of 28 h and a switch time of 1-35 s. The images obtained were processed by using Quantity One v. 4.6.1 software (Bio-Rad).
The genetic relationships among the strains and differences in just one band in the PFGE pattern led us to think that they were different PFGE types (Tenover et al., 1995) . PFGE clustering was determined by using the unweighted-pair group method with arithmetic averages and by using Dice's coefficient. Tolerance was set at 0.8 %. All calculations were performed using InfoQuest software (Applied Maths).
MLST. According to PFGE results, 16 representative isolates of different subtypes in different years (eight strains from 2009, two profile 1, two profile 1b, one profile 1c, two profile 2 and one profile 2b; four from 2010, two profile 2 and two profile 2b; four from 2010, two profile 2c, one profile 2d and one profile 2e) were selected to perform MLST analysis, as described previously (Bartual et al., 2005) (by using the primers described in the Oxford A. baumannii MLST database; http://pubmlst.org/abaumannii/). The amplification product was purified with ExoSAP-IT reagent (Axygen). Sequencing was performed with a BigDye Terminator Cycle Sequencing kit premix version 3 and an ABI 3730 DNA analyser (Applied Biosystems). Analysis of allele sequences and sequence type assignment were performed using the Oxford A. baumannii MLST database.
Mechanisms of carbapenem resistance. Six isolates representing the two different PFGE profiles detected [three strains of profile 1 (one subtype 1, one subtype 1B and one subtype 1C) and three strains of profile 2 (one subtype 2, one subtype 2C and one subtype 2D)] were selected randomly for further molecular studies. Genes coding for OXA-type carbapenemases (bla OXA-23-like , bla OXA-24/40-like , bla OXA-51-like and bla OXA-58-like ) were screened by PCR amplification with specific primers and sequencing (Woodford et al., 2006; Adams-Haduch et al., 2011) . In addition, standard PCR conditions were used to amplify genes coding for other carbapenemases, such as bla VIM , bla IMP , bla NDM , bla KPC and bla OXA-48 .
Furthermore, we used previously published primers to screen for the presence of an ISAba1 insertion element upstream of the bla OXA-51-like gene (Lopes et al., 2012) .
RESULTS

Patients and outbreak evolution
The first outbreak included in the present study appeared in the summer of 2009 in the TRH-ICU. Later, several cases were reported in the MSH-ICU, coinciding with an inpatient transfer from the TRH. After studying the MDRAB strains isolated during this period, we examined 38 patients (Fig. 1) , 25 of which were inpatients of the TRH-ICU (16 were considered infected and nine colonized) and 13 of the MSH-ICU (10 were considered infected and three colonized). We found MDRAB strains related to the outbreak in four of the 21 environmental samples that were studied. One strain was isolated in a parenteral nutrition infusion pump, one in an intravenous infusion pump and the other two in two different beds; all of them in TRH.
The 2010 and 2011 outbreaks were restricted to the MSH-ICU, affecting nine (seven were considered infected and two colonized) and 11 patients (six were considered infected and five colonized), respectively (Fig. 1) . In the 2011 outbreak, we studied 26 isolates of the 11 patients included and no differences between the different isolates from the same patient were found. Therefore, different isolates of the same patient were considered as the same strain.
The epidemiological and genotypic features of the strains isolated from patients during the outbreaks are reported in Table 1 .
Susceptibility testing of MDRAB isolates
All the strains isolated proved to be resistant to penicillins, cephalosporins, fluoroquinolones, trimethoprim/sulfamethoxazole and carbapenems, but were susceptible to colistin, tobramycin and amikacin. We observed variability in susceptibility to gentamicin and ampicillin/sulbactam during the distinct outbreaks (Table 2) ; we found no association with any specific clone.
Molecular epidemiology
Two PFGE profiles were detected among the 77 epidemic isolates. The type 1 profile was presented by three subtypes (1, 1b and 1c) and the type 2 profile was presented by five subtypes (2, 2b, 2c, 2d and 2e). Fig. 2 shows the clustering, period of isolation and number of isolates of the PFGE types. The genetic similarity coefficient for all the PFGE types detected was .80 %.
Two clones (profiles 1 and 2) were identified in the 2009 outbreak. Profile 1 strains were isolated at the TRH, whilst profile 2 was mainly isolated in the MSH. Only one clone was identified in the 2010 and 2011 outbreaks, which was confirmed to be of the same type (profile 2) as that detected in 2009 in the MSH.
After MLST analysis, seven housekeeping genes (gltA, gdhB, recA, cpn60, rpoD, gyrB, and gpi) were amplified and sequenced for each PFGE subtype present in each of the 3 years. A single sequence type (ST92) was identified in the 16 isolates analysed.
Mechanisms of carbapenem resistance
Multiplex PCR for the OXA group enzymes yielded a positive result for the bla OXA-58-like and bla OXA-51-like genes in all six isolates tested, but it was negative for the remaining genes tested. Entire gene sequencing showed the presence of bla OXA-58 .
Amplification with primers FxOxa-F and FxOxa-R by PCR showed the expected product size of 889 bp without any insertion present upstream of the bla OXA-51-like gene.
DISCUSSION
After analysing the data from the three outbreaks we observed that, as had been described in other series, the number of clones associated with multidrug resistance is low. In this case, only two clones were found to be associated, with an 80 % similarity. A single clone (profile 2) -possibly endemic to the MSH-ICU -was isolated in the three outbreaks. This clone causes sporadic outbreaks generally during the spring/summer period, possibly as a result of the rise in temperature, as in other outbreaks described in our community.
Carbapenem resistance is explained by the presence of OXA-58 carbapenemase, without ruling out other mechanisms that may add to its resistance, such as porin loss and overexpresion of efflux pumps (Rumbo et al., 2013) . The presence of plasmidic bla oxa-58-like gene-carrier clones has been associated with their dissemination (Marqué et al., 2005) . Of the 83 carbapenem-resistant A. baumannii clinical isolates collected from a series of patients in Spain, 19.3 % were OXA-58-like producers (Ruiz et al., 2007) . The appearance and clonal dissemination of carbapenemhydrolysing OXA-58-producing A. baumannii isolates have been described recently in Bolivia (Sevillano et al., 2012) .
Although the bla OXA-51-like gene was detected, the absence of ISAba1 upstream of the bla OXA-51-like gene suggests the absence of OXA-51 expression, as has been described previously (Turton et al., 2006; Lopes et al., 2012) . Therefore, bla OXA-51-like was not sequenced entirely because it was not considered important for carbapenem resistance.
Isolates belonging to ST92 have been associated previously with the spread of carbapenem-resistant A. baumannii from a number of European and East Asian countries as well as Australia (Mugnier et al., 2010; Endo et al., 2012; Nigro & Hall, 2012) . In fact, the clonal complex 92 is According to the MLST analysis, the three clinical outbreaks detected are linked to a single MLST clone (ST92). These findings suggest that a single evolved endemic strain can emerge causing localized outbreaks in vulnerable patients. The genetic changes that occurred during the evolution of these bacteria explain the different PFGE profiles detected in this study. This trend of MDRAB towards endemicity is an important threat to the health of inpatients.
It is very difficult to eliminate these bacteria from ICUs, even though drastic measures, such as aggressive infection control strategies, are implemented.
A multidisciplinary approach made it possible to control outbreaks, but it does not guarantee the eradication of the epidemic clones, which may persist in the environment. Screening the environment to find potential reservoirs combined with rigorous environmental cleaning and disinfection protocols, in addition to surveillance of the circulation patterns of these clones, has been described as an efficient strategy to reduce the presence of these bacteria (Tacconelli et al., 2014) . As has been described previously, and as can be observed in our series, the identification of susceptibility patterns is not an adequate method for MDRAB surveillance, as several susceptibility patterns can be identified within one single clone (Fernández-Cuenca et al., 2004) . Consequently, molecular methods of characterization are recommended for the epidemiological surveillance of MDRAB. Sequential outbreaks caused by MDRAB
